baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Vericel Corp/ US92346J1088 /

2024-10-24 9:59:58 PM	Chg. +0.55	Volume	Bid-	Ask-	High	Low
42.83USD	+1.30%	21,991 Turnover: 938,207.05	-Bid Size: -	-Ask Size: -	43.06	42.02

GlobeNewswire 08-29 Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

GlobeNewswire 08-26 Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

GlobeNewswire 08-15 Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Therm...

GlobeNewswire 08-14 MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

GlobeNewswire 08-07 Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

GlobeNewswire 08-01 Vericel Reports Second Quarter 2024 Financial Results

GlobeNewswire 07-22 Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

GlobeNewswire 07-18 Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

GlobeNewswire 06-11 Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

GlobeNewswire 05-29 MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

GlobeNewswire 05-22 Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 20...

GlobeNewswire 05-22 Invivyd Elects Two New Independent Members to its Board of Directors

GlobeNewswire 05-08 Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

GlobeNewswire 04-24 Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

GlobeNewswire 02-29 Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Fina...

GlobeNewswire 02-27 Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

GlobeNewswire 02-15 Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

GlobeNewswire 02-05 Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

GlobeNewswire 01-09 Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

GlobeNewswire 01-09 MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include P...

GlobeNewswire 01-03 Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 20...

GlobeNewswire 2023-12-28 MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for...

GlobeNewswire 2023-11-21 MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update

GlobeNewswire 2023-11-08 Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

GlobeNewswire 2023-11-07 Vericel to Present at the Stephens Annual Investment Conference

Vericel Corp/ US92346J1088 /

If you wish to receive reply to your feedback, please provide your email address.